Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1901 1
1905 3
1908 1
1911 1
1912 1
1913 3
1914 1
1916 2
1917 1
1919 1
1922 1
1923 2
1924 3
1925 1
1927 1
1928 1
1929 1
1932 1
1935 4
1936 3
1937 5
1938 1
1939 4
1940 1
1941 1
1942 2
1943 7
1944 6
1945 4
1946 27
1947 30
1948 33
1949 51
1950 45
1951 64
1952 60
1953 68
1954 67
1955 98
1956 70
1957 66
1958 48
1959 51
1960 53
1961 64
1962 66
1963 88
1964 158
1965 142
1966 185
1967 144
1968 163
1969 172
1970 192
1971 269
1972 189
1973 199
1974 177
1975 221
1976 272
1977 263
1978 282
1979 263
1980 253
1981 325
1982 268
1983 281
1984 277
1985 246
1986 283
1987 299
1988 303
1989 281
1990 340
1991 287
1992 291
1993 384
1994 284
1995 276
1996 265
1997 298
1998 382
1999 320
2000 331
2001 299
2002 291
2003 334
2004 308
2005 347
2006 357
2007 386
2008 436
2009 367
2010 402
2011 447
2012 467
2013 509
2014 481
2015 484
2016 557
2017 612
2018 575
2019 637
2020 807
2021 680
Text availability
Article attribute
Article type
Publication date

Search Results

19,536 results
Results by year
Filters applied: . Clear all
Page 1
Myasthenia gravis: subgroup classification and therapeutic strategies.
Gilhus NE, Verschuuren JJ. Gilhus NE, et al. Lancet Neurol. 2015 Oct;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3. Lancet Neurol. 2015. PMID: 26376969 Review.
Patients with myasthenia gravis should be classified into subgroups to help with therapeutic decisions and prognosis. Subgroups based on serum antibodies and clinical features include early-onset, late-onset, thymoma, MUSK, LRP4, antibody-negative, and ocular forms …
Patients with myasthenia gravis should be classified into subgroups to help with therapeutic decisions and prognosis. Subgroup …
Myasthenia gravis: an update for the clinician.
Sieb JP. Sieb JP. Clin Exp Immunol. 2014 Mar;175(3):408-18. doi: 10.1111/cei.12217. Clin Exp Immunol. 2014. PMID: 24117026 Free PMC article. Review.
This paper provides a thorough overview of the current advances in diagnosis and therapy of myasthenia gravis (MG). Nowadays the term 'myasthenia gravis' includes heterogeneous autoimmune diseases, with a postsynaptic defect of neuromuscular transmissi …
This paper provides a thorough overview of the current advances in diagnosis and therapy of myasthenia gravis (MG). Nowadays t …
Myasthenia Gravis.
Gilhus NE. Gilhus NE. N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678. N Engl J Med. 2016. PMID: 28029925 Review. No abstract available.
Pediatric Myasthenia Gravis.
Peragallo JH. Peragallo JH. Semin Pediatr Neurol. 2017 May;24(2):116-121. doi: 10.1016/j.spen.2017.04.003. Epub 2017 Apr 7. Semin Pediatr Neurol. 2017. PMID: 28941526 Review.
Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of skeletal muscles and fluctuating weakness. Myasthenia that affects children can be classified into the following 3 forms: transient neonatal myasthenia, congenital m
Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of skeletal muscles and fluctuating weakne
Myasthenia gravis: from autoantibodies to therapy.
Mantegazza R, Bernasconi P, Cavalcante P. Mantegazza R, et al. Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596. Curr Opin Neurol. 2018. PMID: 30156572 Review.
The overview is highlighting specifically the data and the needs of targeted treatments in the light of precision medicine in myasthenia gravis. RECENT FINDINGS: Novel data published recently further increased our knowledge on myasthenia gravis. ...SUM …
The overview is highlighting specifically the data and the needs of targeted treatments in the light of precision medicine in myasthenia
Myasthenia gravis: a clinical-immunological update.
Binks S, Vincent A, Palace J. Binks S, et al. J Neurol. 2016 Apr;263(4):826-34. doi: 10.1007/s00415-015-7963-5. Epub 2015 Dec 24. J Neurol. 2016. PMID: 26705120 Free PMC article. Review.
Myasthenia gravis (MG) is the archetypic disorder of both the neuromuscular junction and autoantibody-mediated disease. ...
Myasthenia gravis (MG) is the archetypic disorder of both the neuromuscular junction and autoantibody-mediated disease. ...
[An update on myasthenia gravis].
Martínez Torre S, Gómez Molinero I, Martínez Girón R. Martínez Torre S, et al. Semergen. 2018 Jul-Aug;44(5):351-354. doi: 10.1016/j.semerg.2018.01.003. Epub 2018 Mar 17. Semergen. 2018. PMID: 29555378 Spanish.
Myasthenia gravis is one of the most common disorders that affect neuromuscular transmission. It is currently one of the most understood and characterised autoimmune disorders Its typical symptoms are fluctuating weakness and fatigue that affects a combination of oc
Myasthenia gravis is one of the most common disorders that affect neuromuscular transmission. It is currently one of the most
Ocular myasthenia gravis: a review.
Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Nair AG, et al. Indian J Ophthalmol. 2014 Oct;62(10):985-91. doi: 10.4103/0301-4738.145987. Indian J Ophthalmol. 2014. PMID: 25449931 Free PMC article. Review.
Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. ...Very often, a patient of MG may present to the ophthalmologist given that a large proportion of patients wit
Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscl
Myasthenia gravis: new developments in research and treatment.
Evoli A. Evoli A. Curr Opin Neurol. 2017 Oct;30(5):464-470. doi: 10.1097/WCO.0000000000000473. Curr Opin Neurol. 2017. PMID: 28654435 Review.
PURPOSE OF REVIEW: Myasthenia gravis, a rare disorder of the neuromuscular transmission, is increasingly acknowledged as a syndrome more than as a single disease. ...SUMMARY: In the recent past, there has been an active search for new antigens in myasthenia
PURPOSE OF REVIEW: Myasthenia gravis, a rare disorder of the neuromuscular transmission, is increasingly acknowledged as a syn …
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology.
Hehir MK, Silvestri NJ. Hehir MK, et al. Neurol Clin. 2018 May;36(2):253-260. doi: 10.1016/j.ncl.2018.01.002. Neurol Clin. 2018. PMID: 29655448 Review.
Myasthenia gravis (MG) is a rare disease, but the most common disorder of the neuromuscular junction. ...
Myasthenia gravis (MG) is a rare disease, but the most common disorder of the neuromuscular junction. ...
19,536 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page